106 related articles for article (PubMed ID: 27522526)
1. The Effective Solubilization of Hydrophobic Drugs Using Epigallocatechin Gallate or Tannic Acid-Based Formulations.
Jackson JK; Letchford K
J Pharm Sci; 2016 Oct; 105(10):3143-3152. PubMed ID: 27522526
[TBL] [Abstract][Full Text] [Related]
2. Part 1. Evaluation of Epigallocatechin Gallate or Tannic Acid Formulations of Hydrophobic Drugs for Enhanced Dermal and Bladder Uptake or for Local Anesthesia Effects.
Jackson J; Pandey R; Schmitt V
J Pharm Sci; 2021 Feb; 110(2):796-806. PubMed ID: 33039439
[TBL] [Abstract][Full Text] [Related]
3. Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization.
Jackson J; Schmitt V
J Pharm Sci; 2021 Feb; 110(2):807-814. PubMed ID: 33035538
[TBL] [Abstract][Full Text] [Related]
4. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs.
Kim JY; Kim S; Pinal R; Park K
J Control Release; 2011 May; 152(1):13-20. PubMed ID: 21352878
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.
Jackson JK; Zhao J; Wong W; Burt HM
J Mater Sci Mater Med; 2010 May; 21(5):1435-43. PubMed ID: 20162329
[TBL] [Abstract][Full Text] [Related]
6. Investigation into the mechanism of (-)-epigallocatechin-3-gallate-induced precipitation of insulin.
Wang SH; Dong XY; Sun Y
Int J Biol Macromol; 2012 Jun; 50(5):1229-37. PubMed ID: 22537475
[TBL] [Abstract][Full Text] [Related]
7. Production of monodisperse epigallocatechin gallate (EGCG) microparticles by spray drying for high antioxidant activity retention.
Fu N; Zhou Z; Jones TB; Tan TT; Wu WD; Lin SX; Chen XD; Chan PP
Int J Pharm; 2011 Jul; 413(1-2):155-66. PubMed ID: 21554936
[TBL] [Abstract][Full Text] [Related]
8. Lipophilized epigallocatechin gallate (EGCG) derivatives as novel antioxidants.
Zhong Y; Shahidi F
J Agric Food Chem; 2011 Jun; 59(12):6526-33. PubMed ID: 21526762
[TBL] [Abstract][Full Text] [Related]
9. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
Bianchi A; Marchetti N; Scalia S
J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate decreases the micellar solubility of cholesterol via specific interaction with phosphatidylcholine.
Kobayashi M; Nishizawa M; Inoue N; Hosoya T; Yoshida M; Ukawa Y; Sagesaka YM; Doi T; Nakayama T; Kumazawa S; Ikeda I
J Agric Food Chem; 2014 Apr; 62(13):2881-90. PubMed ID: 24628603
[TBL] [Abstract][Full Text] [Related]
11. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
Krupkova O; Ferguson SJ; Wuertz-Kozak K
J Nutr Biochem; 2016 Nov; 37():1-12. PubMed ID: 27770867
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of Mechanism of Creming-down Phenomenon and Development of High-order Functions Using Tea Catechins].
Ishizu T
Yakugaku Zasshi; 2024; 144(7):715-732. PubMed ID: 38945846
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
14. Transdermal solid delivery of epigallocatechin-3-gallate using self-double-emulsifying drug delivery system as vehicle: Formulation, evaluation and vesicle-skin interaction.
Hu C; Gu C; Fang Q; Wang Q; Xia Q
J Biomater Appl; 2016 Feb; 30(7):1080-91. PubMed ID: 26637442
[TBL] [Abstract][Full Text] [Related]
15. Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells.
Song Q; Li D; Zhou Y; Yang J; Yang W; Zhou G; Wen J
Int J Nanomedicine; 2014; 9():2157-65. PubMed ID: 24855353
[TBL] [Abstract][Full Text] [Related]
16. Enhancing skin penetration of epigallocatechin gallate by modifying partition coefficient using reverse micelle method.
Rosita N; Meitasari VA; Rianti MC; Hariyadi DM; Miatmoko A
Ther Deliv; 2019 Jul; 10(7):409-417. PubMed ID: 31319784
[No Abstract] [Full Text] [Related]
17. Cholinium-based ionic liquids as bioinspired hydrotropes to tackle solubility challenges in drug formulation.
Sintra TE; Abranches DO; Benfica J; Soares BP; Ventura SPM; Coutinho JAP
Eur J Pharm Biopharm; 2021 Jul; 164():86-92. PubMed ID: 33895294
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Bovine Serum Albumin and (-)-Epigallocatechin Gallate/3,4- O-Dicaffeoylquinic Acid/Tannic Acid Layer by Layer Assembled Microcapsule for Protecting Immunoglobulin G in Stomach Digestion and Release in Small Intestinal Tract.
Chen C; Chen G; Wan P; Chen D; Zhu T; Hu B; Sun Y; Zeng X
J Agric Food Chem; 2018 Oct; 66(42):11141-11150. PubMed ID: 30277397
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives.
Henni-Silhadi W; Deyme M; Boissonnade MM; Appel M; Le Cerf D; Picton L; Rosilio V
Pharm Res; 2007 Dec; 24(12):2317-26. PubMed ID: 17912487
[TBL] [Abstract][Full Text] [Related]
20. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
